Hikma Pharmaceuticals (HIK) Ownership - Who Owns Hikma Pharmaceuticals?

118 Followers

Hikma Pharmaceuticals (HIK) Ownership Overview

11.61% Insiders

7.92%

Mutual Funds

6.24% ETFs

74.23% Public Companies and

Individual Investors

The ownership structure of Hikma Pharmaceuticals (GB:HIK) stock is a mix of institutional, retail, and individual investors. , 11.61% is owned by Insiders, and 74.23% is owned by Public Companies and Individual Investors.

The ownership structure of Hikma Pharmaceuticals (GB:HIK) stock is a mix of institutional, retail, and individual investors. Approximately 14.16% of the company’s stock is owned by Institutional Investors, 11.61% is owned by Insiders, and 74.23% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Apr 13, 2026	Sam Park	xxxxxxxxxxxxx	£95020
Apr 13, 2026	Julie Hill	xxxxxxxxxxxxx	£40854
Mar 11, 2026	Hussein Arkhagha	xxxxxxxxxxxxx	£74400
Dec 19, 2025	Mazen Darwazah	xxxxxxxxxxxxx	£1498600

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
14,934,366	Insider	6.83%	247,357,904
8,875,637	Insider	4.06%	147,007,176
5,767,658	Institution	2.64%	95,529,719
4,306,491	Institution	1.97%	71,328,410
3,437,402	Institution	1.57%	56,933,689
2,222,126	Institution	1.02%	36,805,073
2,113,800	Institution	0.97%	35,010,869
1,444,741	Institution	0.66%	23,929,245
815,116	Institution	0.37%	13,500,766
729,888	Institution	0.33%	12,089,135

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
4,306,491	Institution	1.97%	71,328,410
2,222,126	Institution	1.02%	36,805,073
2,113,800	Institution	0.97%	35,010,869
1,444,741	Institution	0.66%	23,929,245
815,116	Institution	0.37%	13,500,766
652,943	Institution	0.30%	10,814,695
630,146	Institution	0.29%	10,437,108
563,618	Institution	0.26%	9,335,205
501,019	Institution	0.23%	8,298,378
407,430	Institution	0.19%	6,748,263

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total International Stock ETF	2,231,944	Institution	1.02%	39,583,610
Vanguard FTSE Developed Markets ETF	1,462,824	Institution	0.67%	25,943,252
iShares Core MSCI EAFE ETF	1,182,218	Institution	0.54%	19,428,076
iShares MSCI EAFE Small-Cap ETF	646,772	Institution	0.30%	10,628,780
Vang FTSE 100 Ptg.Shs GBP	408,308	Institution	0.19%	5,365,167
Vanguard FTSE Europe ETF	386,868	Institution	0.18%	6,861,122
dbxt MSCI EU SM Shs -1C- Capitalisation	361,479	Institution	0.17%	6,095,596
Vanguard FTSE All-World ex-US Index Fund	348,505	Institution	0.16%	6,180,752
Schwab International Small-Cap Equity ETF	311,628	Institution	0.14%	5,254,962
Vanguard International Dividend Appreciation ETF	296,771	Institution	0.14%	5,263,247

FAQ

Who Owns Hikma Pharmaceuticals PLC (GB:HIK)?

Currently, no data Available

What percentage of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by institutional investors?

Currently, no data Available

What percentage of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by retail investors?

According to the latest TipRanks data, approximately 74.23% of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by retail investors.

Who owns the most shares of Hikma Pharmaceuticals PLC (GB:HIK)?

Said Darwazah owns the most shares of Hikma Pharmaceuticals PLC (GB:HIK).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.